Is Focal Segmental Glomerulosclerosis (FSGS) characterized as a nephrotic or nephritic syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

FSGS is Nephrotic

Focal Segmental Glomerulosclerosis (FSGS) is definitively characterized as a nephrotic syndrome, not a nephritic syndrome. 1, 2

Clinical Classification

FSGS accounts for 7-20% of nephrotic syndrome cases in children and a significantly higher percentage in adults, with prevalence as high as 80% among nephrotic patients in Afro-Caribbean populations. 1

The disease presents with the classic features of nephrotic syndrome:

  • Heavy proteinuria (≥3.5 g/day in adults; ≥1.0 g/m²/day in children) 2, 3
  • Hypoalbuminemia (<3.0 g/dL in adults; <2.5 g/dL in children) 2, 3
  • Edema 2, 3
  • Hyperlipidemia (as a compensatory mechanism for protein loss) 2

Pathophysiological Mechanism

The underlying mechanism is podocyte dysfunction leading to increased glomerular permeability to proteins, which is the hallmark of nephrotic rather than nephritic disease. 2 A T-cell-driven circulating "glomerular permeability factor" interferes with glomerular permselectivity to albumin in FSGS. 2

This contrasts sharply with nephritic syndromes, which are characterized by glomerular inflammation, hematuria, hypertension, and acute kidney injury with minimal proteinuria.

Clinical Presentation Patterns

Adults with FSGS typically present with:

  • Proteinuria (often nephrotic-range) 4, 5
  • Microscopic hematuria (may be present but not the dominant feature) 4
  • Hypertension 4
  • Renal insufficiency 4

Patients with persistent nephrotic syndrome have more than 50% risk of progressing to end-stage renal disease within 5-10 years if untreated. 1 Those with proteinuria >3.8 g/day have a 35% risk of end-stage renal disease within 2 years. 2

Nephrotic Complications

FSGS patients experience typical nephrotic complications, not nephritic ones:

  • Thromboembolism risk (29% for renal vein thrombosis, 17-28% for pulmonary embolism) due to loss of anticoagulant proteins 2
  • Increased infection susceptibility due to loss of immunoglobulins and complement factors 2
  • Hyperlipidemia requiring potential statin therapy 3

Common Pitfall

Do not confuse the presence of microscopic hematuria in FSGS with nephritic syndrome. 4 While hematuria can occur in FSGS, the dominant clinical picture is massive proteinuria with nephrotic-range losses, hypoalbuminemia, and edema—the defining features of nephrotic syndrome. The pathophysiology centers on podocyte injury and increased glomerular permeability, not inflammatory glomerular destruction as seen in nephritic syndromes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nephrotic and Nephritic Syndrome Mechanisms and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Criteria and Management of Nephrotic Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Clinical picture and outcome of primary focal segmental glomerulosclerosis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.